Nureain Mirza, MD
Critical Care Medicine · Oak Lawn, ILNPI 1205876414
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Intuitive Surgical at 50.7% of the total. 2025 is the largest year on record at $13,241, more than ten times the $407 reported in 2019. Among critical care medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $111.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- AstraZeneca$6K
- GSK$901
- Boehringer Ingelheim$658
- Jazz Pharmaceuticals Inc.$558
- Inspire Medical Systems, Inc.$294
- plus $2K from 26 others
What the payments were for
- Speaking & faculty fees$5,60026%
- Travel & lodging$8304%
- Food & beverage$5,04023%
- Education$10,20047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $10,986 |
| AstraZeneca | 17 | $6,252 |
| GSK | 49 | $901 |
| Boehringer Ingelheim | 15 | $658 |
| Jazz Pharmaceuticals Inc. | 15 | $558 |
| Inspire Medical Systems, Inc. | 5 | $294 |
| Insmed, Inc. | 10 | $233 |
| Sanofi | 6 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $177 |
| Genentech USA, Inc. | 4 | $153 |
| Merck | 7 | $145 |
| Philips North America LLC | 5 | $141 |
| Pfizer | 6 | $126 |
| Regeneron Healthcare Solutions, Inc. | 3 | $108 |
| ANI Pharmaceuticals, Inc. | 4 | $81 |
| Mallinckrodt Hospital Products Inc. | 2 | $67 |
| Vifor Pharma, Inc. | 2 | $65 |
| Viatris Specialty LLC | 3 | $64 |
| Paratek Pharmaceuticals, Inc. | 3 | $56 |
| Amgen | 3 | $53 |
| Grifols USA, LLC | 3 | $51 |
| Beigene USA, Inc. | 1 | $49 |
| Baxter Healthcare | 1 | $34 |
| Mylan Specialty L.p. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| Pulmonx Corporation | 1 | $22 |
| United Therapeutics Corporation | 1 | $22 |
| Circassia Inc. | 1 | $19 |
| Shionogi Inc | 1 | $19 |
| Harmony Biosciences LLC | 1 | $18 |
| Inogen, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$10,800
- BREZTRI$5,842
- TRELEGY ELLIPTA$222
- Inspire$127
- BENLYSTA$125
- DUPIXENT$124
- AIRSUPRA$121
How this compares
$21,670 in reported general payments places this provider in the 95th percentile of 281 critical care medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 25 | $323,191 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 195 | $225,524 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 81 | $61,914 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 46 | $40,103 |
| Breo ElliptaFluticasone/Vilanterol | 60 | $38,136 |
| Incruse ElliptaUmeclidinium Bromide | 28 | $20,397 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 17 | $12,312 |
| Spiriva RespimatTiotropium Bromide | 12 | $8,717 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 34 | $6,631 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 26 | $6,443 |
| Wixela InhubFluticasone Propion/Salmeterol | 23 | $4,723 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $3,825 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 126 | $3,775 |
| Arnuity ElliptaFluticasone Furoate | 14 | $3,666 |
| Ventolin HfaAlbuterol Sulfate | 35 | $2,293 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $901 | $349,637378 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat | $658 | $344,22054 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $6,252 | $43,92860 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 281 critical care medicine providers in Illinois.
Other critical care medicine in Oak Lawn
- Aman SethiOak Lawn$14K
- Kyle PottsOak Lawn$14K
- Vijayakumar NairOak Lawn$13K
- Vasantha SamalaOak Lawn$3K
- Daniel GonzalezOak Lawn$3K
- Sheri MoonanOak Lawn$2K
- Brian ReichardtO Fallon$892K
- Michael CutticaChicago$402K
- Daniel DillingMaywood$208K
- Israel RubinsteinChicago$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.